fundvisualizer.com

AXS Alternative Value InvestorCOGLX

Performance (before sales charge)

As of 10/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 06/30/2022
Stock
131.51%
Non-U.S. Stock
3.15%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
-4.19%
Other
-30.47%

Due to rounding, percentages may not equal 100%.

Sectors

As of 06/30/2022

Basic materials

0.00%

Consumer cyclical

4.74%

Financial services

20.86%

Real estate

1.85%

Consumer defensive

37.90%

Health care

34.79%

Utilities

4.24%

Communication services

6.49%

Energy

2.21%

Industrials

10.24%

Technology

11.35%

Top 10 holdings

As of 06/30/2022

Other
30.47%
Bnp Borrowing
25.42%
Umb Money Market Fiduciary
21.23%
Vertex Pharmaceuticals Inc
2.31%
AbbVie Inc
2.26%
Coterra Energy Inc Ordinary Shares
2.21%
Centene Corp
2.15%
General Mills Inc
2.14%
The Hershey Co
2.13%
Eli Lilly and Co
2.08%
Fund assets

$21.54 Million

Share class

Inv

Morningstar category

Large Value

Expense ratio

1.57%

Investment objective

Growth

Documents